Gilgamesh Pharmaceuticals
Pursuing several lines of research related to the role of serotonin-signaling in the cortex, demonstrating an important role for cortical influence on behaviors related to schizophrenia and anxiety. His lab also has an active program examining the role of the neurotransmitter serotonin on the development of brain circuits that modulate affective and anxiety states. Additionally, the group has developed a mouse model of epigenetic effects of paternal age on behavior and brain function.
This person is not in any offices
Gilgamesh Pharmaceuticals
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy.